Anirudh Gautam

Dr. Reddy's Laboratories Ltd, Innovation Plaza, Survey Nos. 42, 44, 45 And 54, Quthubullapur, Bachupally, RR Dist
Hyderabad, TG 500090, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Journal: The Journal of clinical and aesthetic dermatology

Published: January 31, 2022

Real-time feedback control of voice in cochlear implant recipients.

Real-time feedback control of voice in cochlear implant recipients.

Journal: Laryngoscope investigative otolaryngology

Published: June 09, 2020

The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers.

The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers.

Journal: British journal of clinical pharmacology

Published: December 09, 2019

Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac®) Cream 0.1.

Bioavailability, Pharmacokinetics, and Transepidermal Water Loss of Short Contact Tazarotene Lotion 0.1% Versus Tazarotene (Tazorac®) Cream 0.1.

Journal: The Journal of clinical and aesthetic dermatology

Published: October 24, 2019

Control of speech and voice in cochlear implant patients.

Control of speech and voice in cochlear implant patients.

Journal: The Laryngoscope

Published: June 11, 2018

Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Males.

Effect of Food on the Pharmacokinetics of 2 Formulations of DRL-17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Males.

Journal: Clinical pharmacology in drug development

Published: May 13, 2018

Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect.

Target site pharmacokinetics of doxycycline for rosacea in healthy volunteers is independent of the food effect.

Journal: British journal of clinical pharmacology

Published: April 18, 2018

Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers.

Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers.

Journal: Clinical drug investigation

Published: July 28, 2017

Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.

Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.

Journal: Journal of clinical pharmacology

Published: March 15, 2017

The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis.

The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis.

Journal: Clinical pharmacology : advances and applications

Published: September 14, 2016

A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.

A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.

Journal: Headache

Published: January 31, 2016

Safety and pharmacokinetics of single and multiple intravenous bolus doses of diclofenac sodium compared with oral diclofenac potassium 50 mg: A randomized, parallel-group, single-center study in healthy subjects.

Safety and pharmacokinetics of single and multiple intravenous bolus doses of diclofenac sodium compared with oral diclofenac potassium 50 mg: A randomized, parallel-group, single-center study in healthy subjects.

Journal: Journal of clinical pharmacology

Published: April 21, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026